| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| xentuzumab | insulin-like growth factor-i | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of prostate[MeSHID:D011471] |
15.91 | phase 2 | unknown |
| xentuzumab | insulin-like growth factor-ii | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant neoplasm of breast[MeSHID:D001943] Malignant neoplasm of prostate[MeSHID:D011471] |
2.27 | phase 2 | unknown |
| click here to return to the previous page | ||||||||